Effect of Rosuvastatin on Outcomes in Chronic Haemodialysis Patients: Baseline Data from the AURORA Study

BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death in patients with end-stage renal disease (ESRD). AIMS: AURORA (A study to evaluate the Use of Rosuvastatin in subjects On Regular haemodialysis: an Assessment of survival and cardiovascular events) is the first large-scale intern...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fellström, Bengt, Holdaas, Hallvard, Jardine, Alan G., Rose, Helen, Schmieder, Roland, Wilpshaar, Wim, Zannad, Faiez
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2007
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2790755/
https://ncbi.nlm.nih.gov/pubmed/17671394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000106803
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars